Dr Reddys Laboratories Share Price Today - Live Blog for November 13, 2025

Dr Reddys Laboratories Ltd shares saw a decrease of -0.12%, reaching a current market price of ₹1,235.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.03%, and as of now, it's trading at ₹1,233.45 per share. This upward trajectory is attracting keen interest from investors.

With a remarkable 0.05% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,232.50. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.8800, while the industry's PE ratio is 33.4675.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.05%. At this moment, it's actively trading at ₹1,232.50, presenting an enticing opportunity for those in the market.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.17% upswing and is currently trading at ₹1,231.90, indicating strong market sentiment.

Dr Reddys Laboratories Ltd's share price has fallen by -0.32%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,228.50, and market participants are assessing the implications. The stock has a PE ratio of 17.8800, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd suffered a -0.24% decline, and it currently trades at ₹1,234.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd witnessed a substantial 0.06% increase in its share price and is currently trading at ₹1,237.95. This remarkable performance has caught the eye of investors.

With a -0.06% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,236.10. Investors should examine the factors driving this decline. The stock's PE ratio is 17.8800, whereas the industry PE ratio stands at 33.4675.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.12%, and as of now, it's trading at ₹1,236.90 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd observed a -0.36% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,236.00. The stock has a PE ratio of 17.8800, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.03% boost, with the current market value at ₹1,240.65 per share. This surge has not gone unnoticed by investors.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.08% increase. Presently, it is actively trading at ₹1,239.65.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.08% in its share price, and it currently trades at ₹1,238.60 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.05% in its share price, and it currently trades at ₹1,239.65 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.41% upswing and is currently trading at ₹1,240.30, indicating strong market sentiment.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.05% increase. Presently, it is actively trading at ₹1,236.40.

Dr Reddys Laboratories Ltd witnessed a -0.16% decrease in its share price, and it is currently trading at ₹1,235.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.8800, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.16%, signalling a challenging period. Currently trading at ₹1,233.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

With a -0.16% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,233.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.8800, while the industry PE is 33.4675.

Dr Reddys Laboratories Ltd's share price has fallen by -0.16%, a situation worth noting. At present, the stock is trading at ₹1,233.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.8800, while the industry PE ratio is 33.4675.

Demonstrating a commendable 0.29% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,234.95. In terms of valuation, the stock maintains a PE ratio of 17.8800, while the industry PE ratio stands at 33.4675.

Dr Reddys Laboratories Ltd witnessed a notable 0.25% surge in its share price and is presently trading at ₹1,231.45, captivating the attention of market participants.

Dr Reddys Laboratories Ltd experienced a -0.24% downturn in its share price, and it's currently trading at ₹1,228.15. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd witnessed a -0.85% decrease in its share price, and it is currently trading at ₹1,231.15. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.8800, an ROE of 16.0277% and a debt to equity ratio of 0.1625.